Nobilis Rismavac + CA 126
Nobilis Rismavac + CA 126
Authorised
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
- Turkey herpesvirus, strain FC-126 (cell-associated), Live
Product identification
Medicine name:
Nobilis Rismavac + CA 126
Active substance:
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
- Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
-
Chicken
Route of administration:
-
In ovo
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live3.00/log10 plaque forming unit(s)1.00Dose
-
Turkey herpesvirus, strain FC-126 (cell-associated), Live3.00/log10 plaque forming unit(s)1.00Dose
Pharmaceutical form:
-
Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
-
In ovo
-
Chicken
-
Meat and offalno withdrawal periodnul dagen
-
Eggno withdrawal periodnul dagen
-
-
-
Intramuscular use
-
Chicken
-
Meat and offalno withdrawal periodnul dagen
-
Eggno withdrawal periodnul dagen
-
-
-
Subcutaneous use
-
Chicken
-
Meat and offalno withdrawal periodnul dagen
-
Eggno withdrawal periodnul dagen
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Available in:
-
Netherlands
Package description:
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 8869
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 1/11/2024